Home » Topics » Disease categories and therapies » Cancer

Cancer
RSS

New antiinflammatory IKK-2 inhibitors in early development at AstraZeneca

March 17, 2003

Teva invests in Gamida-Cell

March 14, 2003

OSI to market Novantrone in oncology indications

March 14, 2003

Lorus allowed U.S. patent that protects key antisense target

March 14, 2003

Kosan Biosciences receives SBIR grant to develop production method for laulimalide

March 14, 2003

Transarterial 131I-lipiodol in HCC

March 13, 2003

Ariad focuses resources on anticancer candidates

March 13, 2003

Novel series of antiangiogenic tyrosine kinase inhibitors for cancer and other disorders

March 13, 2003

Novel agents for enhancing DNA-damaging antitumor activity

March 13, 2003

Quinoline Src kinase inhibitors in AstraZeneca pipeline

March 13, 2003

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for June 18, 2026.
News in brief
BioWorld Asia
BioWorld Asia briefs for June 16, 2026
For clonal hematopoiesis, epigenetics can be in driver’s seat
BioWorld Science
Clonal hematopoiesis (CH), where few blood stem cells produce a significant fraction of mature blood cells that are genetically identical, is partly an inevitable...
Elixiron’s enrupatinib shows upbeat interim phase II AD results
BioWorld
Elixiron Immunotherapeutics Inc. announced positive interim open-label phase II Alzheimer’s disease (AD) study findings of enrupatinib, an oral brain-penetrant...
Gene replacement rescues autism-related phenotypes in mice
BioWorld Science
Autism spectrum disorder (ASD), developmental epileptic encephalopathies and other neurodevelopmental disorders are driven by the disruption of genes regulating...